Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 97.05
-3.05 (-3.05%)
Aug 13, 2026, 3:13 PM AST
Dallah Healthcare Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,293 | 4,067 | 3,206 | 2,943 | 2,488 | 2,105 | |
Revenue Growth | 20.87% | 26.86% | 8.93% | 18.28% | 18.18% | 59.69% |
Cost of Revenue | 2,856 | 2,678 | 2,073 | 1,921 | 1,631 | 1,361 |
Gross Profit | 1,437 | 1,389 | 1,133 | 1,021 | 857.34 | 744.2 |
Selling, General & Admin | 842.73 | 771.47 | 560.22 | 519.68 | 437.06 | 399.18 |
Other Operating Expenses | 12.38 | -26.34 | -25.11 | -33.87 | -4.06 | -33.46 |
Operating Expenses | 905.95 | 794.75 | 565.51 | 515.07 | 439.05 | 382.82 |
Operating Income | 531.16 | 594.4 | 567.16 | 506.4 | 418.29 | 361.38 |
Interest Expense | -171.66 | -147.6 | -106.69 | -104.14 | -70.49 | -36.5 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.01 | 3.08 | 3.18 |
Earnings From Equity Investments | 50.35 | 51.7 | 42.97 | -1.86 | -22.82 | -31.08 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -5.33 |
EBT Excluding Unusual Items | 409.86 | 498.52 | 503.45 | 400.42 | 328.06 | 291.65 |
Gain (Loss) on Sale of Investments | 51.43 | 51.43 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.43 | -0.43 | -0.05 | -0.1 | 1.07 | 0.19 |
Other Unusual Items | 0 | 0 | - | - | - | - |
Pretax Income | 460.87 | 549.53 | 503.4 | 400.32 | 329.13 | 291.84 |
Income Tax Expense | 18.91 | 8.99 | 18.22 | 14.89 | 33.69 | 16.93 |
Earnings From Continuing Operations | 441.96 | 540.54 | 485.18 | 385.42 | 295.44 | 274.91 |
Minority Interest in Earnings | 1.02 | -2.27 | -13.97 | -25.3 | -20.98 | -16.31 |
Net Income | 442.98 | 538.27 | 471.2 | 360.12 | 274.46 | 258.6 |
Net Income to Common | 442.98 | 538.27 | 471.2 | 360.12 | 274.46 | 258.6 |
Net Income Growth | -14.79% | 14.23% | 30.84% | 31.21% | 6.13% | 95.92% |
Shares Outstanding (Basic) | 102 | 101 | 98 | 97 | 90 | 90 |
Shares Outstanding (Diluted) | 102 | 101 | 98 | 97 | 90 | 90 |
Shares Change | 3.62% | 3.74% | 0.20% | 8.16% | - | 4.56% |
EPS (Basic) | 4.34 | 5.32 | 4.83 | 3.70 | 3.05 | 2.87 |
EPS (Diluted) | 4.34 | 5.32 | 4.83 | 3.70 | 3.05 | 2.87 |
EPS Growth | -17.77% | 10.12% | 30.59% | 21.31% | 6.13% | 87.38% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -64.57 | 90.1 | 314.65 | 331.28 | 269.44 | 245.93 |
Free Cash Flow Per Share | -0.63 | 0.89 | 3.23 | 3.40 | 2.99 | 2.73 |
Dividend Per Share | 2.000 | 2.000 | 2.000 | 1.500 | 2.500 | 1.500 |
Dividend Growth | 0% | 0% | 33.33% | -40.00% | 66.67% | 100.00% |
Gross Margin | 33.48% | 34.16% | 35.33% | 34.71% | 34.46% | 35.35% |
Operating Margin | 12.37% | 14.62% | 17.69% | 17.21% | 16.81% | 17.17% |
Profit Margin | 10.32% | 13.23% | 14.70% | 12.24% | 11.03% | 12.28% |
Free Cash Flow Margin | -1.50% | 2.22% | 9.81% | 11.26% | 10.83% | 11.68% |
EBITDA | 721.13 | 770.57 | 682.13 | 610.37 | 514.18 | 458.56 |
EBITDA Margin | 16.80% | 18.95% | 21.28% | 20.74% | 20.67% | 21.78% |
D&A For EBITDA | 189.97 | 176.17 | 114.97 | 103.97 | 95.89 | 97.18 |
EBIT | 531.16 | 594.4 | 567.16 | 506.4 | 418.29 | 361.38 |
EBIT Margin | 12.37% | 14.62% | 17.69% | 17.21% | 16.81% | 17.17% |
Effective Tax Rate | 4.10% | 1.64% | 3.62% | 3.72% | 10.24% | 5.80% |
Advertising Expenses | - | 84.96 | 48.65 | 39.82 | 25.92 | 25.84 |